Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy

Clonal cytogenetic evolution with additional chromosomal abnormalities (ACAs) in chronic myelogenous leukemia (CML) is generally associated with decreased response to tyrosine kinase inhibitor (TKI) therapy and adverse survival. Although ACAs are considered as a sign of disease progression and have...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Wang, Wei, Cortes, Jorge E., Tang, Guilin, Khoury, Joseph D., Wang, Sa, Bueso-Ramos, Carlos E., DiGiuseppe, Joseph A., Chen, Zi, Kantarjian, Hagop M., Medeiros, L. Jeffrey, Hu, Shimin
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2016
Assuntos:
Myeloid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4915795/
https://ncbi.nlm.nih.gov/pubmed/27006386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-01-690230
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados